-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
AFL reported Q1 2026 adjusted EPS of $1.75 versus $1.66 (+5.4%), topping our $1.58 estimate but missing the $1.80 consensus view, with currency headwinds creating a $0.02 negative impact. Net EPS surged to $1.98 from $0.05 (+3,860%) due to a significant swing in investment performance, with net gains of $49M versus $963M in losses. We view the strong underlying insurance operations as encouraging despite persistent Japanese yen weakness affecting results. Management is expected to update its 2026 outlook and sales forecast on tomorrow's conference call. Japan showed particular strength with new annualized premium sales surging 25.5% to 17.7B ($113M), due to successful product launches including Anshin Palette medical insurance and Miraito cancer insurance. U.S. sales growth of 2.9% to $318M primarily reflected group products, though we expect continued distribution challenges given the company's dependence on independent agents in an increasingly digital marketplace.